Custom design and validation of dCas9/dCas12a-mediated gene repression for your target genes.
CRISPR interference (CRISPRi) enables targeted, reversible gene repression in Saccharomyces cerevisiae without introducing double-strand breaks. Our service provides end-to-end support from guide RNA design to validated engineered strains.
We design, build, and validate CRISPRi constructs tailored to your project goals.
Guide RNAs are designed using proprietary algorithms to evaluate on-target repression while minimizing off-target effects. gRNAs are cloned into expression vectors encoding a catalytically dead Cas9 or Cas12a fused to a transcriptional repressor domain.
Our system supports inducible CRISPRi using β-estradiol-responsive promoters, allowing temporal control of gene repression. Constitutive expression is also available when constant silencing is preferred.
We provide validated dCas9/dCas12a repressor constructs and gRNA expression cassettes for transformation into S. cerevisiae strains.
Scoped per project after consultation.
Services are scaled to your needs—single gene targets, multiplexed repression, or library-scale screens—with deliverables defined per SOW.
Our standard handoff includes engineered strains, validation data, and project documentation.
All aspects are defined during consultation to match your research needs.
| Parameter | Typical project scope |
|---|---|
| Target Gene Selection | Single gene, gene family, or pathway; specified by customer or recommended by our bioinformatics team |
| GRNA Design & Synthesis | 2-4 gRNAs per target; design based on promoter/ORF region; synthesis included |
| CRISPRi System | DCas9-Mxi1, dCas9-MIG1, or dCas12a-repressor; choice depends on PAM preference and target AT-content |
| Inducibility | β-estradiol inducible or constitutive expression; induction conditions optimized per strain |
| Multiplexing | Up to 4 gRNAs per vector (dCas12a array); multiple target repression in a single transformation |
| Strain Background | Laboratory strains (e.g., BY4741, W303) or industrial strains; compatibility assessed |
| Validation Method | QRT-PCR or fluorescence reporter (e.g., GFP) depending on target; fold-repression reported |
| Number of Clones | Typically 3–5 verified clones per target; more upon request |
| Technical Support | Named scientific contact at project start; milestone review calls; email response within 1 business day |
A streamlined process with clear milestones and deliverables at each stage.
Our bioinformatics team identifies optimal gRNA sequences targeting your gene(s) of interest. We evaluate promoter versus ORF targeting for maximal repression, and design multiple candidates for best efficiency.
GRNA oligonucleotides are cloned into expression plasmids containing dCas9 or dCas12a fused to a repressor domain. The final construct is sequence-verified before transformation.
The CRISPRi plasmid is transformed into your chosen S. cerevisiae strain using a standard lithium acetate protocol. Successful transformants are selected on appropriate auxotrophic or antibiotic markers.
For inducible systems, repression is triggered by adding β-estradiol to the culture medium. Cells are grown under selective pressure to maintain the plasmid, and repression is allowed to establish over several generations.
Repression efficiency is quantified by qRT-PCR or fluorescence reading. At least three independent clones per target are characterized. Data and engineered strains are delivered in a final report.
Our service supports a wide range of research and biotechnology needs.
Fine-tune expression of endogenous or heterologous genes to redirect carbon flux toward desired products.
Identify genes required for growth under specific conditions or uncover new functions in uncharacterized open reading frames.
Identify and repress negative regulators of stress tolerance to evaluate performance in industrial fermentation environments.
Common questions about our CRISPRi gene repression service.
Repression efficiency is target- and locus-dependent. In typical projects, we observe project-dependent performance that is verified during development knockdown at the mRNA level as measured by qRT-PCR. The exact fold-repression is reported for each target and depends on gRNA design, promoter strength, and induction conditions.
Yes. Using dCas12a (Cpf1) allows processing of a single CRISPR RNA array to generate multiple gRNAs, enabling multiplexed repression. We routinely design arrays for 2–4 targets. For higher multiplexing, please discuss with our team during project scoping.
Our inducible CRISPRi system using β-estradiol provides reversible repression.Removal of the inducer leads to gradual recovery of target gene expression.
We perform colony PCR to verify construct integration or plasmid maintenance, Sanger sequencing of the gRNA cassette, and qRT-PCR (or fluorescence reporter assay) to quantify repression. Growth curves are measured to confirm no unintended fitness defects.
Yes. We can adapt the CRISPRi system to polyploid industrial strains, though transformation efficiency and repression levels may differ from haploid laboratory strains. Compatibility is assessed during the initial consultation.
Get a customized quote for your Precision Gene Silencing in Saccharomyces cerevisiae project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.